Progesterone enhances cytokine-stimulated nitric oxide synthase II expression and cell death in human breast cancer cells

Laboratory Investigation

Volumn 85, Issue 5, 2005, Pages 624-632

  Bentrari, Fatima ^a   Arnould, Laurent ^a,b   Jackson, Antony P ^c   Jeannin, Jean Francois ^a   Pance, Alena ^a,c  

^a UNIVERSITÉ DE BOURGOGNE   (France)

^b CENTRE GEORGES FRANÇOIS LECLERC   (France)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Apoptosis; Breast cancer; Nitric oxide; NOSII; Progesterone; Transcription

Indexed keywords

CYTOKINE; ESTRADIOL; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; NITRIC OXIDE; PROGESTERONE; PROGESTERONE RECEPTOR; STEROID HORMONE; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CANCER SURVIVAL; CELL DEATH; CELL VIABILITY; HORMONAL THERAPY; HUMAN; HUMAN CELL; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOCARCINOMA; APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CYTOKINES; DRUG COMBINATIONS; DRUG SYNERGISM; ESTRADIOL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PROGESTERONE; RNA, MESSENGER; RNA, NEOPLASM; TRANSCRIPTION, GENETIC;

EID: 18744385845     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1038/labinvest.3700267     Document Type: Article

References (44)

1. Forstermann U, Gloss EI, Pollock JS, et al. Nitric oxide synthase isozymes. Characterization, purification, molecular cloning, and functions. Hypertension 1994;23:1121-1131.
2. Forstermann U, Boissel JP, Kleinert H. Expressional control of the 'constitutive' isoforms of nitric oxide synthase (NOS I and NOS III). FASEB J 1998;12:773-790.
3. Xu W, Liu LZ, Loizidou M, et al. The role of nitric oxide in cancer. Cell Res 2002;12:311-320.
4. Rao KM. Molecular mechanisms regulating iNOS expression in various cell types. J Toxicol Environ Health B Grit Rev 2000;3:27-58.
5. Taylor BS, de Vera ME, Ganster RW, et al. Multiple NF-kappaB enhancer elements regulate cytokine induction of the human inducible nitric oxide synthase gene. J Biol Chem 1998;273:15148-15156.
6. Kristof AS, Marks-Konczalik J, Moss J. Mitogen-activated protein kinases mediate activator protein-1-dependent human inducible nitric-oxide synthase promoter activation. J Biol Chem 2001;276:8445-8452.
7. Kleinert H, Wallerath T, Fritz G, et al. Cytokine induction of NO synthase II in human DLD-1 cells: roles of the JAK-STAT, AP-1 and NF-kappaB-signaling pathways. Br J Pharmacol 1998;125:193-201.
8. Jenkins NA, Rothe H, Gilbert DJ, et al. Mapping of the gene for inducible nitric oxide (NO) synthase of mouse macrophages to chromosome 11, close to Evi-2, nu, and Idd-4. Genomics 1994;19:402-404.
9. Jenkins DC, Charles IG, Thomsen LL, et al. Roles of nitric oxide in tumor growth. Proc Natl Acad Sci USA 1995;92:4392-4396.
10. Xie K, Huang S, Dong Z, et al. Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis by K-1735 murine melanoma cells. J Exp Med 1995;181:1333-1343.
11. Reveneau S, Arnould L, Jolimoy G, et al. Nitric oxide synthase in human breast cancer is associated with tumor grade, proliferation rate, and expression of progesterone receptors. Lab Invest 1999;79:1215-1225.
12. Ambs S, Merriam WG, Bennett WP, et al. Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression. Cancer Res 1998;58:334-341.
13. Tschugguel W, Schneeberger C, Unfried G, et al. Expression of inducible nitric oxide synthase in human breast cancer depends on tumor grade. Breast Cancer Res Treat 1999;56:145-151.
14. Vakkala M, Kahlos K, Lakari E, et al. Inducible nitric oxide synthase expression, apoptosis, and angiogenesis in in situ and invasive breast carcinomas. Clin Cancer Res 2000;6:2408-2416.
15. Knight WA, Livingston RB, Gregory EJ, et al. Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer. Cancer Res 1977;37:4669-4671.
16. Mason BH, Holdaway IM, Mullins PR, et al. Progesterone and estrogen receptors as prognostic variables in breast cancer. Cancer Res 1983;43:2985-2990.
17. McGuire WL, Osborne CK, Clark GM, et al. Steroid hormone receptors and carcinoma of the breast. Am J Physiol 1982;243:E99-E102.
18. Howell A, Barnes DM, Harland RN, et al. Steroid-hormone receptors and survival after first relapse in breast cancer. Lancet 1984;1:588-591.
19. Alanko A, Heinonen E, Scheinin T, et al. Significance of estrogen and progesterone receptors, disease-free interval, and site of first metastasis on survival of breast cancer patients. Cancer 1985;56:1696-1700.
20. Vakkala M, Paakko P, Soini Y. eNOS expression is associated with the estrogen and progesterone receptor status in invasive breast carcinoma. Int J Oncol 2000;17:667-671.
21. Kleinert H, Wallerath T, Euchenhofer C, et al. Estrogens increase transcription of the human endothelial NO synthase gene: analysis of the transcription factors involved. Hypertension 1998;31:582-588.
22. Yallampalli C, Dong YL. Estradiol-17beta inhibits nitric oxide synthase (NOS)-II and stimulates NOS-III gene expression in the rat uterus. Biol Reprod 2000;63:34-41.
23. de Vera ME, Shapiro RA, Nussler AK, et al. Transcriptional regulation of human inducible nitric oxide synthase (NOS2) gene by cytokines: initial analysis of the human NOS2 promoter. Proc Natl Acad Sci USA 1996;93:1054-1059.
24. Pance A, Chantome A, Reveneau S, et al. A represser in the proximal human inducible nitric oxide synthase promoter modulates transcriptional activation. FASEB J 2002;16:631-633.
25. Goldring CE, Reveneau S, Chantome A, et al. Heat shock enhances transcriptional activation of the murine-inducible nitric oxide synthase gene. FASEB J 2000;14:2393-2395.
26. Green LC, Wagner DA, Glogowski J, et al. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem 1982;126:131-138.
27. Moudgil VK, Dinda S, Khattree N, et al. Hormonal regulation of tumor suppressor proteins in breast cancer cells. J Steroid Biochem Mol Biol 2001;76:105-117.
28. Kleinert H, Euchenhofer C, Fritz G, et al. Involvement of protein kinases in the induction of NO synthase II in human DLD-1 cells. Br J Pharmacol 1998;123:1716-1722.
29. Huang J, Roby KF, Pace JL, et al. Cellular localization and hormonal regulation of inducible nitric oxide synthase in cycling mouse uterus. J Leukoc Biol 1995;57:27-35.
30. Keith Bechtel M, Bonavida B. Inhibitory effects of 17beta-estradiol and progesterone on ovarian carcinoma cell proliferation: a potential role for inducible nitric oxide synthase. Gynecol Oncol 2001;82:127-138.
31. Kohmura Y, Kirikae T, Kirikae F, et al. Onapristone (ZK299) blocks the suppressive effect of progesterone, but not that of dexamethasone, on inducible nitric oxide synthase gene expression and nitric oxide production in murine macrophages. Int J Immunopharmacol 2000;22:765-774.
32. Salzman AL, Linn SC, Szabo C. Progesterone inhibits inducible nitric oxide synthase mRNA expression in human intestinal epithelial cells. Int J Mol Med 2000;6:209-216.
33. Dormond O, Lejeune FJ, Ruegg C. Modulation of cdk2, cyclin D1, p16INK4a, p21WAF and p27Kip1 expression in endothelial cells by TNF/IFN gamma. Anticancer Res 2002;22:3159-3163.
34. Haynes MP, Li L, Sinha D, et al. Src kinase mediates phosphatidylinositol 3-kinase/Akt-dependent rapid endothelial nitric-oxide synthase activation by estrogen. J Biol Chem 2003;278:2118-2123.
35. Martin JH, Begum S, Alalami O, et al. Endothelial nitric oxide synthase: correlation with histologic grade, lymph node status and estrogen receptor expression in human breast cancer. Tumour Biol 2000;21:90-97.
36. Zeillinger R, Tantscher E, Schneeberger C, et al. Simultaneous expression of nitric oxide synthase and estrogen receptor in human breast cancer cell lines. Breast Cancer Res Treat 1996;40:205-207.
37. Ou J, Ou Z, Ackerman AW, et al. Inhibition of heat shock protein 90 (hsp90) in proliferating endothelial cells uncouples endothelial nitric oxide synthase activity. Free Radic Biol Med 2003;34:269-276.
38. Tschugguel W, Knogler W, Czerwenka K, et al. Presence of endothelial calcium-dependent nitric oxide synthase in breast apocrine metaplasia. Br J Cancer 1996;74:1423-1426.
39. Garban HJ, Bonavida B. Nitric oxide sensitizes ovarian tumor cells to Fas-induced apoptosis. Gynecol Oncol 1999;73:257-264.
40. Horita K, Inase N, Miyake S, et al. Progesterone induces apoptosis in malignant mesothelioma cells. Anticancer Res 2001;21:3871-3874.
41. Gompel A, Somai S, Chaouat M, et al. Hormonal regulation of apoptosis in breast cells and tissues. Steroids 2000;65:593-598.
42. Kloke O, Klaassen U, Oberhoff C, et al. Maintenance treatment with medroxyprogesterone acetate in patients with advanced breast cancer responding to chemotherapy: results of a randomized trial. Essen Breast Cancer Study Group. Breast Cancer Res Treat 1999;55:51-59.
43. Focan C, Beauduin M, Salamon E, et al. Adjuvant high-dose medroxyprogesterone acetate for early breast cancer: 13 years update in a multicentre randomized trial. Br J Cancer 2001;85:1-8.
44. Franke HR, Vermes I. The effect of continuous combined 17beta-oestradiol and dihydrodydrogesterone on apoptotic cell death and proliferation of human breast cancer cells in vitro. Eur J Cancer 2002;38(Suppl 6):S69-S70.